Compugen (CGEN) Cash from Operations (2009 - 2010)
Compugen (CGEN) reported Cash from Operations of 831000.0 for Q4 2010, up 60.05% on a YoY basis from 519218.98 in Q4 2009, and down 99.76% sequentially from 416000.0 in Q3 2010.
Compugen (CGEN) Cash from Operations (2009 - 2010) Analysis & Trends
Compugen (CGEN) has 2 years of Cash from Operations data on file, last reported at 831000.0 in Q4 2010.
- For the quarter ending Q4 2010, Cash from Operations rose 60.05% year-over-year to 831000.0; the trailing twelve-month figure through Dec 2010 stood at 4280000.0 (changed N/A YoY), and the FY2025 full-year result was 31634000.0, down 36.23% from the prior year.
- Cash from Operations fell to 831000.0 in Q4 2010, from 416000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 416000.0 in Q3 2010 to a low of 2080000.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -831,000.00 |
| Dec 31, 2010 | -831,000.00 |
| Sep 30, 2010 | -416,000.00 |
| Sep 30, 2010 | -416,000.00 |
| Dec 31, 2009 | -2.08 Mn |
| Dec 31, 2009 | -2.08 Mn |
| Sep 30, 2009 | -953,000.00 |
| Sep 30, 2009 | -953,000.00 |